Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers

BACKGROUND: Chemo-immunotherapy (CIT) is the standard of care for advanced non-small cell lung cancer (NSCLC), but the impact of routinely available histo-molecular biomarkers on its efficacy has not yet been fully assessed. OBJECTIVE: The purpose of this multicenter study was to evaluate the clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchal, Marine, Leroy, Vincent, Behal, Hélène, Dansin, Eric, Paris, Nicolas, Bordier, Soraya, Humez, Sarah, Escande, Fabienne, Gauvain, Clément, Cortot, Alexis B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663251/
https://www.ncbi.nlm.nih.gov/pubmed/37921939
http://dx.doi.org/10.1007/s11523-023-01009-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663251/
https://www.ncbi.nlm.nih.gov/pubmed/37921939
http://dx.doi.org/10.1007/s11523-023-01009-w

Ejemplares similares